<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320719">
  <stage>Registered</stage>
  <submitdate>19/10/2009</submitdate>
  <approvaldate>20/10/2009</approvaldate>
  <actrnumber>ACTRN12609000908235</actrnumber>
  <trial_identification>
    <studytitle>Preoperative oral paracetamol versus intraoperative intravenous paracetamol: plasma levels in the recovery room</studytitle>
    <scientifictitle>Does giving paracetamol intravenously during an operation result in significantly higher plasma paracetamol levels in the early postoperative period than giving the same dose orally as a premedicant?</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Postoperative plasma paracetamol levels</healthcondition>
    <healthcondition>Postoperative pain scores</healthcondition>
    <healthcondition>Postoperative analgesia requirements</healthcondition>
    <healthcondition>Length of stay in recovery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>1 g intravenous (IV) paracetamol given intraoperatively</interventions>
    <comparator>1g oral paracetamol given 30-60 minutes preoperatively</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Plasma paracetamol levels from venous blood sample taken from contralateral arm to the drip.
Assay performed by Canterbury Health Laboratories using a colourimetric assay on the c8000 analysers.  Units in mcmol/l.</outcome>
      <timepoint>30 minutes after arrival in the recovery room</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Postoperative pain scores at 10 minute intervals using a 100mm visual analogue scale (VAS)</outcome>
      <timepoint>10 minute intervals until discharge from recovery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Postoperative rescue analgesia requirements (fentanyl mcg)</outcome>
      <timepoint>Total amount required during the patient's stay in recovery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of stay in recovery  ie how long it took for patient to reach standard discharge criteria from recovery</outcome>
      <timepoint>Duration of stay in reocvery</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Day case arthroscopies
Suitable for laryngeal mask anaesthesia
American Society of Anaesthesiologists (ASA) 1 &amp; 2
Body mass index (BMI) less than 35</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contraindication to paracetamol
BMI over 35 
Requiring intubation rather than laryngeal mask airway (LMA) use
Requiring any other intraoperative analgesics other than IV fentanyl</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subjects enrolled by study investigator on the day of admission.  Letter explaining trial also sent to patients prior to their surgery.
Oral tablets (either active paracetamol or placebo) administered from sealed numbered envelopes.  Placebo identical to active tablets.
Tablets administered by blinded nurse.</concealment>
    <sequence>Randomised using a computer generated vector (prepared by our statistician).</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Bio-availability</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>8/01/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Canterbury</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Christchurch Public Hospital</primarysponsorname>
    <primarysponsoraddress>2 Riccarton Avenue
Addington
8011
Christchurch</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Christchurch Public Hospital</fundingname>
      <fundingaddress>2 Riccarton Avenue
Addington
8011
Christchurch</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Burwood Hospital</sponsorname>
      <sponsoraddress>225 Mairehau Rd
Burwood 8083
Christchurch</sponsoraddress>
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Paracetamol is traditionally given by anaesthetists in tablet form around one hour before an operation with the intention of providing good pain relief in the period following the operation.  Recently, an IV formulation has become available and can be given during the operation.  We compared which of these techniques gave higher levels of paracetamol in the bloodstream after the operation.  We also looked at how much extra pain relief was needed in the recovery room, how long patients stayed in the recovery room and how sore they were.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Upper South A Ethics Committee</ethicname>
      <ethicaddress>C/O Ministry of Health
4th floor
250 Oxford Tce
Central Christchurch
8011
PO Box 3877</ethicaddress>
      <ethicapprovaldate>12/11/2008</ethicapprovaldate>
      <hrec>URA/08/09/060</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Christian Brett</name>
      <address>C/o Department of Anaesthesia
Christchurch Public Hospital
2 Riccarton Ave
8011
Private Bag 4710</address>
      <phone>+64 3 3640288</phone>
      <fax>+64 3 3490420</fax>
      <email>christian.brett@cdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Christian Brett</name>
      <address>C/o Department of Anaesthesia
Christchurch Public Hospital
2 Riccarton Ave
Private Bag 4710
8011
Christchurch</address>
      <phone>+64 3 3640288</phone>
      <fax>+64 3 3490420</fax>
      <email>christian.brett@cdhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Sheila Barnett</name>
      <address>C/o Department of Anaesthesia
Christchurch Public Hospital
Riccarton Ave
8011
Private Bag 4710</address>
      <phone>+64 3 3640288</phone>
      <fax>+64 3 3490420</fax>
      <email>sheila80@doctors.org.uk</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>